- Home
- FNWD vs SERA Comparison
FNWD vs SERA Comparison
Compare FNWD & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNWD | SERA |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.6M | 130.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FNWD | SERA |
|---|---|---|
| Price | $39.08 | $3.59 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 37.4K | ★ 51.3K |
| Earning Date | 01-27-2026 | 11-13-2025 |
| Dividend Yield | ★ 1.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $66,563,999.00 | $95,000.00 |
| Revenue This Year | N/A | $19.22 |
| Revenue Next Year | $8.03 | $400.00 |
| P/E Ratio | $20.07 | ★ N/A |
| Revenue Growth | N/A | ★ 1.06 |
| 52 Week Low | $26.12 | $1.37 |
| 52 Week High | $39.99 | $9.13 |
Technical Indicators
Market Signals| Indicator | FNWD | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 60.23 |
| Support Level | $38.44 | $3.20 |
| Resistance Level | $39.35 | $3.72 |
| Average True Range (ATR) | 1.14 | 0.27 |
| MACD | -0.20 | 0.05 |
| Stochastic Oscillator | 43.65 | 81.88 |
Price Performance
Historical ComparisonAbout FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.